Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease
NCT00835887 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-09-23
Summary
In this study, the acute and long-term effects of flavanols on vascular function in patients with ESRD will be investigated.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
low and high dose flavanoids
treatment with flavanoid-rich or flavanoid-low cacao twice daily
Sponsors & Collaborators
-
Heinrich-Heine University, Duesseldorf
collaborator OTHER -
RWTH Aachen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Germany
Study Locations
More Related Trials
-
Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
NCT02791906 ·Status: TERMINATED ·Phase: PHASE2
-
Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
NCT03423810 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced Nephropathy
NCT01142024 ·Status: COMPLETED ·Phase: NA
-
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
NCT01144091 ·Status: WITHDRAWN ·Phase: NA
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Intravenous Iron Administration in Hemodialysis Patients
NCT00298441 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Acute MI Study
NCT01580566 ·Status: COMPLETED
-
Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury in Patients With Heart Failure
NCT02642081 ·Status: UNKNOWN
-
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
NCT00575419 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
NCT01232257 ·Status: COMPLETED ·Phase: PHASE3
-
Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease
NCT07235891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Sympatholysis in Chronic Kidney Disease
NCT02411773 ·Status: RECRUITING ·Phase: PHASE1
-
N-acetylcysteine to Prevent Renal Failure
NCT01359722 ·Status: UNKNOWN ·Phase: NA
-
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
NCT05264584 ·Status: COMPLETED ·Phase: NA
-
Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy
NCT04531163 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
NCT01403506 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Arginase Inhibition in Ischemia-reperfusion Injury
NCT02009527 ·Status: COMPLETED ·Phase: PHASE1
-
Reduce Bolus Injection of Bivalirudin
NCT03588611 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis
NCT00440869 ·Status: COMPLETED ·Phase: PHASE1
-
Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
NCT01458158 ·Status: UNKNOWN
-
Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
NCT00452192 ·Status: COMPLETED ·Phase: PHASE3
-
Optimalization of Nephroprotection Using N-Acetylcysteine
NCT00572663 ·Status: COMPLETED ·Phase: NA
-
L-Citrulline in Peripheral Artery Disease
NCT02521220 ·Status: COMPLETED ·Phase: NA
-
Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
NCT00506506 ·Status: COMPLETED ·Phase: PHASE3